Unlock stock picks and a broker-level newsfeed that powers Wall Street.

ASX - Delayed Quote AUD

Australian Clinical Labs Limited (ACL.AX)

3.1100
+0.0100
+(0.32%)
As of 11:38:42 AM GMT+10. Market Open.

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.
NameTitlePayExercisedYear Born
Ms. Melinda McGrath CEO & Executive Director 1.21M -- --
Mr. Darren McKee Chief Executive Officer of Victoria 37.27k -- --
Mr. Matthew Cordingley Chief Financial Officer -- -- --
Mr. Anthony Friedli Chief Operating Officer -- -- --
Mr. Sean Jackson Chief Information Officer -- -- --
Mr. Joe Geran National Marketing Director -- -- --
Associate Prof. Tony Landgren National Medical Director & Chief Pathologist -- -- --
Mr. Chris Brownlow Chief Executive Officer of New South Wales & Australian Capital Territory -- -- --
Ms. Shae Seymour Chief Executive Officer of WA/SA/NT -- -- --
Ms. Eleanor Padman B.A., FCIS Company Secretary -- -- --

Australian Clinical Labs Limited

1868-1892 Dandenong Road
Clayton, VIC 3168
Australia
61 1 3004 53688 https://www.clinicallabs.com.au
Sector: 
Healthcare
Full Time Employees: 
4,900

Description

Australian Clinical Labs Limited provides pathology diagnostic services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services. It offers its service to private and public hospitals. The company was incorporated in 2020 and is headquartered in Clayton, Australia.

Corporate Governance

Australian Clinical Labs Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

February 25, 2025 at 9:30 PM UTC

Australian Clinical Labs Limited Earnings Date

Recent Events

March 27, 2025 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers

Waiting for permission
Allow microphone access to enable voice search

Try again.